Simona Musella

Via G. Paolo II 132
Salerno, 84084, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Identification of a New, Potent, and Stable Tetrahydroquinoline-Based 5-LOX/sEH Dual Inhibitor with Polymodal Anti-Inflammatory Activity in Acute Pancreatitis.

Identification of a New, Potent, and Stable Tetrahydroquinoline-Based 5-LOX/sEH Dual Inhibitor with Polymodal Anti-Inflammatory Activity in Acute Pancreatitis.

Journal: Journal of medicinal chemistry

Published: July 27, 2026

Metabolic Reprogramming Associated with Ferroptosis Protection by an Indole-Based Antioxidant in Aβ(25-35)-Treated SH-SY5Y Cells.

Metabolic Reprogramming Associated with Ferroptosis Protection by an Indole-Based Antioxidant in Aβ(25-35)-Treated SH-SY5Y Cells.

Journal: Antioxidants (Basel, Switzerland)

Published: April 16, 2026

New TRPM8 Amino Acid-Based Antagonists Induce Antiproliferative Effect on 2D and 3D Melanoma and Prostate Cancer Models.

New TRPM8 Amino Acid-Based Antagonists Induce Antiproliferative Effect on 2D and 3D Melanoma and Prostate Cancer Models.

Journal: Journal of medicinal chemistry

Published: February 11, 2026

Targeting Cathepsins in Neurodegeneration: Biochemical Advances.

Targeting Cathepsins in Neurodegeneration: Biochemical Advances.

Journal: Biomedicines

Published: November 21, 2025

An adamantylureido-benzylamide aniline as FLAP/sEH dual inhibitor: Rational design, in vitro and in vivo lipidomic profiling.

An adamantylureido-benzylamide aniline as FLAP/sEH dual inhibitor: Rational design, in vitro and in vivo lipidomic profiling.

Journal: European journal of medicinal chemistry

Published: September 25, 2025

Rewiring melanoma cell fate: TRPM8 modulators trigger apoptosis and boost NK cell cytotoxicity.

Rewiring melanoma cell fate: TRPM8 modulators trigger apoptosis and boost NK cell cytotoxicity.

Journal: Cell death & disease

Published: July 30, 2025

Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.

Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening, Bioinformatics, and Omics for Target Deconvolution.

Journal: Journal of medicinal chemistry

Published: July 24, 2025

Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization.

Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization.

Journal: ChemMedChem

Published: March 31, 2025

Neuroprotective Potential of Indole-Based Compounds: A Biochemical Study on Antioxidant Properties and Amyloid Disaggregation in Neuroblastoma Cells.

Neuroprotective Potential of Indole-Based Compounds: A Biochemical Study on Antioxidant Properties and Amyloid Disaggregation in Neuroblastoma Cells.

Journal: Antioxidants (Basel, Switzerland)

Published: November 12, 2024

Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress.

Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress.

Journal: Antioxidants (Basel, Switzerland)

Published: October 03, 2024

A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors.

A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors.

Journal: Journal of medicinal chemistry

Published: July 22, 2024

Voltage-Gated K+ Channel Modulation by Marine Toxins: Pharmacological Innovations and Therapeutic Opportunities.

Voltage-Gated K+ Channel Modulation by Marine Toxins: Pharmacological Innovations and Therapeutic Opportunities.

Journal: Marine drugs

Published: June 10, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026